Brain tumours represent the leading cause of childhood cancer related death, historically treated with surgery, radiation and non-specific chemotherapy.
Despite aggressive therapies, survival has been stagnant for over 30 years while most children continue to fail.
Those that survive are left with lifelong side effects.
Our team aims to bridge this gap in knowledge by seeking to develop and evaluate more precise and less toxic treatment strategies.